Watch List for Equities Hitting New High -- Research on SanDisk, Universal Health Services, Sesa Sterlite and Durata Therapeutics
Editor Note: For more information about this release, please scroll to bottom.
LONDON, May 21, 2014 /PRNewswire/ --
The US markets on Tuesday, May 20, 2014 ended on a negative note as the Dow Jones Industrial Average finished at 16,374.31, down 0.83% and the NASDAQ Composite closed at 4,096.89, down 0.70%. The S&P 500 finished the session 0.65% lower at 1,872.83. During the trading session, nine out of ten sectors ended on a lower note. Investor-Edge looks at some of the equities that hit a new 52-week high during the last session. These include SanDisk Corporation (NASDAQ: SNDK), Universal Health Services Inc (NYSE: UHS), Sesa Sterlite Ltd (NYSE: SSLT) and Durata Therapeutics Inc. (NASDAQ: DRTX). Free technical research on SNDK, UHS, SSLT and DRTX can be downloaded upon signing up at:
SanDisk Corp.'s stock ended the day at $91.37, down 0.26%, after hitting a new 52-week high of $92.26. A total of 2.13 million shares were traded, which was below its three months average volume of 3.83 million shares. The stock vacillated between $90.65 and $92.26 during the session. Over the last one month and the previous three months, SanDisk Corp.'s shares have surged 10.10% and 21.33%, respectively. Moreover, since the beginning of the year, the company's stock has gained an upside of 29.53%. The S&P 500 Information Technology Sector Index mapped a loss of 0.49% during the session, while the index has gained 1.79% in the last one month. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $81.88 is greater than its 200-day moving average of $70.22. SanDisk Corp.'s stock has a Relative Strength Index (RSI) of 69.81. Sign up today to read free research on SNDK at:
On Tuesday, shares in Universal Health Services Inc. oscillated between $85.97 and $87.33, hitting a new 52-week high of $87.33. Shares in the company advanced 1.45%, to end the session at $87.23. The company's stock reported a trading volume of 0.77 million shares, below its three months average volume of 0.83 million shares. Shares of the company traded at a PE ratio of 18.86. Universal Health Services Inc.'s shares have gained 2.70% in the previous three trading sessions, 16.85% in the last one month, and 7.35% on YTD basis. The S&P 500 Health Care Sector Index registered a loss of 0.62% during the session, while the index has gained 2.04% in the last one month. Universal Health Services Inc.'s stock is trading above its 50-day and 200-day moving averages of $79.46 and $78.36, respectively. Moreover, shares of the company have an RSI of 67.28. Sign up today to read free research on UHS at:
Shares in Sesa Sterlite Ltd surged 5.70% on Tuesday, finishing the day at $16.50, hitting a new 52-week high of $16.58. The stock recorded a trading volume of 0.94 million shares, much above its three months average volume of 0.22 million shares. The stock oscillated between $16.13 and $16.58 during the trading session. Over the last three trading sessions and past one month, Sesa Sterlite Ltd's shares have rallied 28.40% and 29.11%, respectively. Further, the stock has gained 25.38% since the start of this year. The S&P 500 Materials Sector Index recorded a loss of 0.56% during the session, while the index has gained 0.56% in the last one month. The stock is trading above its 50-day moving average of $12.35. Additionally, Sesa Sterlite Ltd's stock has an RSI of 80.03. Sign up today to read free research on SSLT at:
On Tuesday, shares in Durata Therapeutics Inc. surged 2.08%, closing the day at $16.72, after hitting a new 52-week high of $17.20. The stock recorded a trading volume of 0.73 million shares, above its three month average volume of 0.44 million shares. Durata Therapeutics Inc.'s shares have gained 2.51% in the previous three trading sessions, 31.97% in the last one month, and 30.73% on YTD basis. The S&P 500 Health Care Sector Index has advanced 0.37% during the previous three trading sessions, while the index has lost 1.33% in the past three months. Durata Therapeutics Inc.'s stock is trading above its 50-day and 200-day moving averages of $14.01 and $11.45, respectively. Furthermore, shares of the company have an RSI of 70.48. Sign up today to read free research on DRTX at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.